Equity Profile

DHR

Danaher Corporation

Health CareLife Sciences Tools & Services$129.3B

Jul21Tue

Pre-Earnings Brief

UpcomingQ2-2026Pre-Market9:00 AM EDT

Company Snapshot

Danaher Corporation (DHR) operates in the health care sector, focusing on life sciences tools and services. The company plays a crucial role in providing innovative solutions for diagnostics, bioprocessing, and environmental monitoring, which are essential for improving health outcomes and scientific research.

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of the company's profitability and performance, which investors closely watch.

N/A

Revenue Growth

Revenue growth reflects the company's ability to expand its business and capture market share in the health care sector.

N/A

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

DHR Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

88%

Avg EPS Surprise

+7.56%

Avg Stock Reaction

-0.36%

Last Quarter Recap

In Q1-2026, Danaher reported an EPS of $2.06, exceeding expectations by 5.91%. However, the stock experienced a slight decline of 0.49% the following day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Overall expectations for Danaher's upcoming earnings are mixed, given the lack of analyst estimates and management guidance. Investors are keen to see if the company can continue its trend of beating EPS expectations.

Bull Case

If Danaher can report strong revenue growth and maintain or improve its operating margins, it could signal robust demand for its products, leading to a positive market reaction.

Bear Case

Conversely, if the company fails to meet EPS expectations or shows signs of declining margins, it could lead to a significant drop in stock price, as seen in past quarters.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will be the reported EPS for Q2-2026?

The EPS figure will be crucial in determining if Danaher can maintain its history of beating expectations, which could influence investor sentiment.

How is Danaher addressing potential supply chain challenges?

Given the current economic environment, any commentary on supply chain management will be critical for assessing future revenue growth and operational efficiency.

Edge

What the Street Is Missing

Why consensus could be wrong

The market may be underestimating Danaher's ability to leverage its innovative product pipeline, which could lead to stronger-than-expected revenue growth this quarter.

Supporting Evidence

Danaher has consistently beaten EPS estimates in the past, with an 88% success rate.

The options market is pricing in a significant move, suggesting that traders expect volatility that may not align with current consensus.

Recent trends in health care spending indicate a potential increase in demand for Danaher's products.

Key Risk

If revenue growth exceeds expectations, it could challenge the current cautious outlook.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The core thesis revolves around Danaher's ability to sustain its growth trajectory amidst economic uncertainties and competitive pressures.

Bull Confirmed If

A reported EPS of $2.10 or higher would confirm strong operational performance and investor confidence.

Bear Confirmed If

An EPS below $1.95 would raise concerns about profitability and market demand.

Pre-Earnings Positioning

Options Market

Implied Move

±7.99%

Historical Avg

±4.4%

Pricing rich

The options market is pricing in a nearly 8% move, indicating that traders expect significant volatility around the earnings report.

Options are pricing ±8.0% while DHR has averaged ±4.4% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.4%

30d HV

29.5%

Calls (164K)P/C Ratio: 0.32Puts (289K)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter beat + options rich in Health Care

n=30

Fade rate: 13 of 29 (45%)

This setup has occurred 30 times across Health Care in the last 2 years. 13 of 29 faded and 16 held — no strong directional bias after the initial reaction. The average absolute 1-day move is 5.5%, with a raw directional average of +2.9% (modestly positive historical bias).

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Danaher beats expectations, history suggests a potential stock increase of around 0.98%, confirming the company's strong performance.

In-Line / Cautious

If results are in line with expectations, the stock may experience minimal movement as investors await further guidance from management.

Miss

A miss could lead to a decline of approximately 9.73%, reflecting investor disappointment and concerns about future growth.

Preparation

Congressional Activity

House & Senate STOCK Act disclosures over the trailing 6 months.

Trades

0 buys·1 sell

Members

House only

Est. Notional

$1,001.00–$15,000.00

disclosed dollar ranges

Most Active Members

D-TXJulie JohnsonRep.
1

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches and their expected impact on revenue.
2Insights into customer demand trends in the life sciences sector.
3Management's perspective on supply chain stability and cost management.
4Guidance on operating margins for the upcoming quarters.
5Comments on competitive pressures and market positioning.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

ICICI Bank Limited

Company Snapshot

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of the company's profitability and performance, which investors closely watch.

N/A

Revenue Growth

Revenue growth reflects the company's ability to expand its business and capture market share in the health care sector.

N/A

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

DHR Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

88%

Avg EPS Surprise

+7.56%

Avg Stock Reaction

-0.36%

Last Quarter Recap

In Q1-2026, Danaher reported an EPS of $2.06, exceeding expectations by 5.91%. However, the stock experienced a slight decline of 0.49% the following day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Bull Case

If Danaher can report strong revenue growth and maintain or improve its operating margins, it could signal robust demand for its products, leading to a positive market reaction.

Bear Case

Conversely, if the company fails to meet EPS expectations or shows signs of declining margins, it could lead to a significant drop in stock price, as seen in past quarters.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will be the reported EPS for Q2-2026?

The EPS figure will be crucial in determining if Danaher can maintain its history of beating expectations, which could influence investor sentiment.

How is Danaher addressing potential supply chain challenges?

Given the current economic environment, any commentary on supply chain management will be critical for assessing future revenue growth and operational efficiency.

Edge

What the Street Is Missing

Why consensus could be wrong

The market may be underestimating Danaher's ability to leverage its innovative product pipeline, which could lead to stronger-than-expected revenue growth this quarter.

Supporting Evidence

Danaher has consistently beaten EPS estimates in the past, with an 88% success rate.

The options market is pricing in a significant move, suggesting that traders expect volatility that may not align with current consensus.

Recent trends in health care spending indicate a potential increase in demand for Danaher's products.

Key Risk

If revenue growth exceeds expectations, it could challenge the current cautious outlook.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The core thesis revolves around Danaher's ability to sustain its growth trajectory amidst economic uncertainties and competitive pressures.

Bull Confirmed If

A reported EPS of $2.10 or higher would confirm strong operational performance and investor confidence.

Bear Confirmed If

An EPS below $1.95 would raise concerns about profitability and market demand.

Pre-Earnings Positioning

Options Market

Implied Move

±7.99%

Historical Avg

±4.4%

Pricing rich

The options market is pricing in a nearly 8% move, indicating that traders expect significant volatility around the earnings report.

Options are pricing ±8.0% while DHR has averaged ±4.4% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.4%

30d HV

29.5%

Calls (164K)P/C Ratio: 0.32Puts (289K)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter beat + options rich in Health Care

n=30

Fade rate: 13 of 29 (45%)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Danaher beats expectations, history suggests a potential stock increase of around 0.98%, confirming the company's strong performance.

In-Line / Cautious

If results are in line with expectations, the stock may experience minimal movement as investors await further guidance from management.

Miss

A miss could lead to a decline of approximately 9.73%, reflecting investor disappointment and concerns about future growth.

Preparation

Congressional Activity

House & Senate STOCK Act disclosures over the trailing 6 months.

Trades

0 buys·1 sell

Members

House only

Est. Notional

$1,001.00–$15,000.00

disclosed dollar ranges

Most Active Members

D-TXJulie JohnsonRep.
1

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches and their expected impact on revenue.
2Insights into customer demand trends in the life sciences sector.
3Management's perspective on supply chain stability and cost management.
4Guidance on operating margins for the upcoming quarters.
5Comments on competitive pressures and market positioning.